WASHINGTON, DC (GenomeWeb News) – Australian molecular diagnostics developer Proteome Systems has closed a private placement of AUD$2.5 million (US$2.2 million), the company said today.
 
Proteome Systems will issue 23,809,524 shares at AUD$0.105 per share to participants in the funding including Oppenheimer Funds and other US and Australian investors.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.